SCHEMBL30737138

SCHEMBL30737138

COC(=O)[C@H](CCC(C)(C)C)NC(=O)c1ccc(Oc2cccc(C(=O)OC(C)(C)C)c2)nc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 3/20 0.65
GRN P28799 2/20 0.65
CTSA P10619 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
CASP3 P42574 1/20 0.40
KMT2A Q03164 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRM5 P41594 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
GABRA5 P31644 1/20 0.38
KDR P35968 1/20 0.37
LIPE Q05469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737387 1.00 SORT1 (0.65) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL30737105 0.91 SORT1 (0.69) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL30736918 0.91 SORT1 (0.69) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL31646343 0.89 GRN (0.52) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL30737615 0.89 SORT1 (0.67) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL30737290 0.87 SORT1 (0.57) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL31646163 0.86 SORT1 (0.66) SORT1GRNCTSAL3MBTL1GAA
SCHEMBL30737298 0.86 SORT1 (0.67) SORT1GRNCTSAGAAMEN1
SCHEMBL31646309 0.83 SORT1 (0.56) SORT1GRNCTSAGABRA5LIPE
SCHEMBL30737412 0.83 SORT1 (0.61) SORT1GRNCTSAGRM5OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 SORT1 1/4885GRN 842/4885CTSA 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.